BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36419386)

  • 1. Lack of SIRP-alpha reduces lung cancer growth in mice by promoting anti-tumour ability of macrophages and neutrophils.
    Pan L; Wang B; Chen M; Ma Y; Cui B; Chen Z; Song Y; Hu L; Jiang Z
    Cell Prolif; 2023 Feb; 56(2):e13361. PubMed ID: 36419386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRP-alpha-IL-6 axis induces immunosuppressive macrophages in non-small-cell lung cancer.
    Wang B; Pan L; Chen M; Ma Y; Gao J; Tang D; Jiang Z
    Biochem Biophys Res Commun; 2023 Nov; 682():386-396. PubMed ID: 37844448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.
    Kuo TC; Chen A; Harrabi O; Sockolosky JT; Zhang A; Sangalang E; Doyle LV; Kauder SE; Fontaine D; Bollini S; Han B; Fu YX; Sim J; Pons J; Wan HI
    J Hematol Oncol; 2020 Nov; 13(1):160. PubMed ID: 33256806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells.
    Andrejeva G; Capoccia BJ; Hiebsch RR; Donio MJ; Darwech IM; Puro RJ; Pereira DS
    J Immunol; 2021 Feb; 206(4):712-721. PubMed ID: 33431660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis.
    Shen Q; Zhao L; Pan L; Li D; Chen G; Chen Z; Jiang Z
    Front Immunol; 2022; 13():865579. PubMed ID: 35634325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel CD47-blocking peptide fused to pro-apoptotic KLA repeat inhibits lung cancer growth in mice.
    Pan L; Hu L; Chen M; Song Y; Chen Z; Gu Y; Li C; Jiang Z
    Cancer Immunol Immunother; 2023 Dec; 72(12):4179-4194. PubMed ID: 37831145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint.
    Voets E; Paradé M; Lutje Hulsik D; Spijkers S; Janssen W; Rens J; Reinieren-Beeren I; van den Tillaart G; van Duijnhoven S; Driessen L; Habraken M; van Zandvoort P; Kreijtz J; Vink P; van Elsas A; van Eenennaam H
    J Immunother Cancer; 2019 Dec; 7(1):340. PubMed ID: 31801627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin.
    Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A
    Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RRx-001 Acts as a Dual Small Molecule Checkpoint Inhibitor by Downregulating CD47 on Cancer Cells and SIRP-α on Monocytes/Macrophages.
    Cabrales P
    Transl Oncol; 2019 Apr; 12(4):626-632. PubMed ID: 30738349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-SIRP
    Yanagita T; Murata Y; Tanaka D; Motegi SI; Arai E; Daniwijaya EW; Hazama D; Washio K; Saito Y; Kotani T; Ohnishi H; Oldenborg PA; Garcia NV; Miyasaka M; Ishikawa O; Kanai Y; Komori T; Matozaki T
    JCI Insight; 2017 Jan; 2(1):e89140. PubMed ID: 28097229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 12. Signal regulatory protein alpha blockade potentiates tumoricidal effects of macrophages on gastroenterological neoplastic cells in syngeneic immunocompetent mice.
    Abe T; Tanaka Y; Piao J; Tanimine N; Oue N; Hinoi T; Garcia NV; Miyasaka M; Matozaki T; Yasui W; Ohdan H
    Ann Gastroenterol Surg; 2018 Nov; 2(6):451-462. PubMed ID: 30460349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis.
    Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC
    J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch Signaling Modulates Macrophage Polarization and Phagocytosis Through Direct Suppression of Signal Regulatory Protein α Expression.
    Lin Y; Zhao JL; Zheng QJ; Jiang X; Tian J; Liang SQ; Guo HW; Qin HY; Liang YM; Han H
    Front Immunol; 2018; 9():1744. PubMed ID: 30105024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury.
    Elberg G; Liraz-Zaltsman S; Reichert F; Matozaki T; Tal M; Rotshenker S
    J Neuroinflammation; 2019 Dec; 16(1):277. PubMed ID: 31883525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages.
    Sakamoto M; Murata Y; Tanaka D; Kakuchi Y; Okamoto T; Hazama D; Saito Y; Kotani T; Ohnishi H; Miyasaka M; Fujisawa M; Matozaki T
    Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34949714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model.
    Feng Y; Yan S; Lam SK; Ko FCF; Chen C; Khan M; Ho JC
    Lung Cancer; 2022 Dec; 174():14-26. PubMed ID: 36272280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewis Lung Cancer Cells Promote SIGNR1(CD209b)-Mediated Macrophages Polarization Induced by IL-4 to Facilitate Immune Evasion.
    Yan X; Li W; Pan L; Fu E; Xie Y; Chen M; Mu D
    J Cell Biochem; 2016 May; 117(5):1158-66. PubMed ID: 26447454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.